Progress in therapeutic targets on podocyte for Alport syndrome

被引：0
|
作者：
Zheng, Qimin [1 ,2 ]
Gu, Xiangchen [1 ,2 ]
He, John Cijiang [3 ]
Xie, Jingyuan [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Sch Med, Dept Nephrol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Inst Nephrol, Sch Med, Shanghai, Peoples R China
[3] Icahn Sch Med Mt Sinai, Dept Med, Barbara T Murphy Div Nephrol, New York, NY USA
来源：
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE | 2024年 / 12卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Alport syndrome; podocyte; therapeutic targets; UNFOLDED PROTEIN RESPONSE; IV COLLAGEN; CELL-CYCLE; DISEASE PROGRESSION; MUTATIONS; GLOMERULI; AUTOPHAGY; FIBROSIS; STRESS;
D O I：
10.2478/jtim-2024-0005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：129 / 133
页数：5
相关论文
共 50 条
  • [1] Podocyte Depletion in Thin GBM and Alport Syndrome
    Wickman, Larysa
    Hodgin, Jeffrey B.
    Wang, Su Q.
    Afshinnia, Farsad
    Kershaw, David
    Wiggins, Roger C.
    PLOS ONE, 2016, 11 (05):
  • [2] Mechanisms and Implications of Podocyte Autophagy in Alport Syndrome
    Njeim, Rachel
    Ficarella, Maria
    Fontanella, Antonio Miguel
    Gye, Haley
    Kim, Jin Ju
    Mitrofanova, Alla
    Ali, Hassan
    Merscher, Sandra M.
    Fornoni, Alessia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [3] Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
    Ge, Mengyuan
    Molina, Judith
    Kim, Jin-Ju
    Mallela, Shamroop K.
    Ahmad, Anis
    Varona Santos, Javier
    Al-Ali, Hassan
    Mitrofanova, Alla
    Sharma, Kumar
    Fontanesi, Flavia
    Merscher, Sandra
    Fornoni, Alessia
    ELIFE, 2023, 12
  • [4] Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome
    Ding, Fangrui
    Wickman, Larysa
    Wang, Su Q.
    Zhang, Yanqin
    Wang, Fang
    Afshinnia, Farsad
    Hodgin, Jeffrey
    Ding, Jie
    Wiggins, Roger C.
    KIDNEY INTERNATIONAL, 2017, 92 (06) : 1515 - 1525
  • [5] Effect of disease progression on the podocyte cell cycle in Alport Syndrome
    Frank, Camille Nicolas
    Hou, Xiaogang
    Petrosyan, Astgik
    Villani, Valentina
    Zhao, Rui
    Hansen, Joshua R.
    Clair, Geremy
    Salem, Fadi
    De Filippo, Roger E.
    Cravedi, Paolo
    Lemley, Kevin, V
    Perin, Laura
    KIDNEY INTERNATIONAL, 2022, 101 (01) : 106 - 118
  • [6] Identification of Novel Therapeutic Targets for Alport Syndrome Using Near SuperResolution Imaging of Podocytes
    Brathwaite, Kaye E.
    Polin, Queen
    Puapatanakul, Pongpratch
    Qu Chengqing
    Suleiman, Hani
    Miner, Jeffrey H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [7] New therapeutic options for Alport syndrome
    Torra, Roser
    Furlano, Monica
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1272 - 1279
  • [8] Podocyte p53 Limits the Severity of Experimental Alport Syndrome
    Fukuda, Ryosuke
    Suico, Mary Ann
    Kai, Yukari
    Omachi, Kohei
    Motomura, Keishi
    Koga, Tomoaki
    Komohara, Yoshihiro
    Koyama, Kosuke
    Yokota, Tsubasa
    Taura, Manabu
    Shuto, Tsuyoshi
    Kai, Hirofumi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (01): : 144 - 157
  • [9] Impact of Glomerular Basement Membrane Stiffness on Podocyte Metabolism in Alport Syndrome
    Kim, Jin Ju
    Ficarella, Maria
    David, Molina Judith T.
    Fontanesi, Flavia
    Merscher, Sandra M.
    Miner, Jeffrey H.
    Fornoni, Alessia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] Alport Syndrome: Clinical Spectrum and Therapeutic Advances
    De Gregorio, Vanessa
    Caparali, Emine Bilge
    Shojaei, Azadeh
    Ricardo, Samantha
    Barua, Moumita
    KIDNEY MEDICINE, 2023, 5 (05)
12345